The Use of Artificial Intelligence in Gastrointestinal Oncology
Once you're logged in, please select the "REGISTER" tab to process your payment and complete your registration.
After you register, you'll receive an email with instructions on how to complete your registration through Zoom.
If you have questions, please email Kim Carstens at email@example.com.
Physicians, advanced practice providers, nurses, radiation therapists, residents, medical students, and other interested healthcare providers.
To provide insight and updates on the complexities of managing gastrointestinal cancers to a multidisciplinary population of healthcare providers.
- Illustrate the use of artificial intelligence in diagnosing gastrointestinal malignancies.
- Compare enhanced imaging of gastrointestinal polyps with traditional histopathology.
- Review current clinical applications of computer-aided diagnosis during colonoscopy.
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy and fourth leading cause of cancer death worldwide. Colonoscopy has demonstrated efficacy in preventing CRC by detecting and removing neoplastic lesions. There is concerning variability in colonoscopy's diagnostic performance, leading to widespread efforts to improve quality and reduce operator dependence.
Computer-aided diagnosis (CAD) offers a promising solution to reduce variation in colonoscopy performance. Pooled miss rates as high as 22% for polyps and associated interval colorectal cancers following colonoscopy are concerning.
Meanwhile, the concept of ‘optical biopsy’ where in vivo classification of polyps based on enhanced imaging replaces histopathology, has not been incorporated into routine practice, largely limited by inter-observer variability and generally meeting accepted standards only in expert settings. Real-time decision support software has been developed to detect and characterize polyps while also offering feedback on the technical quality of the inspection. Some of the current algorithms, particularly with recent advances in artificial intelligence techniques, now match human expert performance for optical biopsy.
Manish Chand, MBBS, BSc, FRCS, FASCRS, MBA, PhD
Associate Professor of Surgery, Director of Advanced MIS Programme, Consultant Colorectal Surgeon, University College London
- FASCRS: American Society of Colorectal Surgeons
- PhD: Imperial College London
- FRCS: General Surgery and Colorectal Surgery (CCT) and Royal College of Surgeons (England)
- MBA: University of Leicester Business School
- MRCS: The Surgical Royal Colleges of Great Britain and Ireland
- MBBS: Royal Free and University College, University of London
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and MercyOne Cancer Center Des Moines. DMU is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
No ineligible company provided financial support for this continuing education activity.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with commercial interest companies to disclose.
- Kim Carstens, BSN, RN, OCN - Activity Director and Planning Committee Member
Relevant to the content of this educational activity, the following individual has a conflict an ineligible company to disclose. All relevant financial relationships have been mitigated.
- Manish Chand, MBBS, BSc, FRCS, FASCRS, MBA, PhD - Speaker, Consultant, Lightpoint Medical
The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2A
- 1.00 CE Contact Hour(s)
- 1.00 IBON
The cost to attend is $10 per person.
- All cancellations must be received in writing at firstname.lastname@example.org.
- A nonrefundable administrative fee of $5 will be charged for all cancellations.
- No refunds will be given three (3) business days prior to the activity start date.
- Cancelled registrations can be transferred to another individual for the same activity.
- Individuals who fail to attend the activity (no-shows) will not receive any refund. Forfeited fees may not be applied to any other activity.